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Synovial sarcoma is a malignant mesenchymal neoplasm that is frequently misdiagnosed as a benign condition
because of its small size, slow growth, and well-delineated appearance. Rapid spread and early death occur rarely.
Here we report a case of synovial sarcoma of the buttocks presenting with a non-healing wound and rapid
progression after local resection in a 23-year-old woman. She initially found a slightly painful subcutaneous mass in
the left buttock and underwent local excision. Postoperatively, she developed a non-healing wound that did not
respond to conventional antibiotic therapy and local wound care, and pitting edema of the lower extremities. A
magnetic resonance imaging scan revealed a large heterogeneous, irregular mass in the buttocks with regional
lymph node involvement. Histological and immunohistochemical analyses suggested the diagnosis of a poorly
differentiated synovial sarcoma. Her condition deteriorated dramatically shortly thereafter; she developed systemic
edema and died of respiratory failure. This case suggests that synovial sarcoma may be fatal within months of
recognition if improperly managed and stresses the importance of adequate pre-surgical evaluation and
postoperative pathological analysis in the management of a subcutaneous mass.
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Synovial sarcoma is a malignant mesenchymal neoplasm
that constitutes 8 to 10% of all sarcomas and has an an-
nual incidence of 2.5 per 100,000. It mainly affects adults
in the third to fifth decades of life [1] and usually arises
in the extremities, especially the lower extremities
around the knees [2]. This malignancy has a highly vari-
able course. It is frequently misdiagnosed as a benign
condition as a consequence of its small size, slow growth
and well-delineated appearance. Overall, survival rates
are 23.5 to 64% at 5 years and 11.2 to 34% at 10 years
[3]. Rapid spread and early death occur infrequently. In
addition, the development of non-healing wounds fol-
lowing local resection is rarely seen in patients with a
synovial sarcoma. Here, we report a case of synovial* Correspondence: zzhuo@hotmail.com
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healing wound and rapid progression after local
resection.Case presentation
A 23-year-old woman was admitted to our hospital due
to the development of a non-healing postoperative
wound for approximately 4 months. In January 2011, she
found a slightly painful subcutaneous mass that mea-
sured 1 × 1.5 cm in the left buttock and underwent local
excision at a local hospital. On postoperative day 2, she
developed bleeding from the wound and received
hemostatic interventions. However, the wound remained
unhealed and continued to produce purulent exudates,
with no obvious improvement after repeated dressing
changes. On March 26th, 2011, the patient was referred
to another hospital, where she underwent surgical de-
bridement. Postoperatively, the wound deteriorated rap-
idly and developed a cauliflower-like growth. Meanwhile,
she developed pitting edema of the lower extremities.
Her general condition worsened.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the time of presentation, her general condition was poor
and she had severe pallor. Her body posture was con-
strained and she could only sleep on the right side. There
was obvious pitting edema of the bilateral lower extrem-
ities (especially the left side) and the lower abdomen. A T-
shaped incision was noted on her left buttock. The
cauliflower-like lesion measured 15× 20 cm and was suffi-
ciently deep to reach the ischial tuberosity, with a large
amount of purulent discharge (Figure 1). Multiple inguinal
lymph nodes were enlarged, hard, painful palpable, and
fused together. Laboratory investigations revealed a red
blood cell count of 1.39× 1012/L, hemoglobin was 31 g/L,
white blood cell count was 16.54 × 109/L, neutrophil per-
centage was 83.6%, platelet count was 322× 109/L, and the
albumin level was 14.3 g/L.
A magnetic resonance imaging (MRI) scan was per-
formed, which revealed a large heterogeneous, irregular
mass in the buttocks, buttock ulceration, and multiple
enlarged pelvic and inguinal lymph nodes that were
fused together (Figure 2). An initial diagnosis of soft tis-
sue sarcoma with lymph node metastasis was made.
Small biopsy specimens were then taken and subjected
to pathological examination, which revealed focal necro-
sis and tumor components. Numerous small round cells,
with mostly oval nuclei and scarce cytoplasm, were seen
(Figure 3). Immunohistochemically, the tumor cells were
strongly positive for vimentin and calretinin (Figure 4A,
B), moderately positive for CD99 and epithelial mem-
brane antigen (EMA) (Figure 4C,D), partially positive for
cytokeratin and Ki67 (Figure 4E,F), but negative for
actin, S-100, desmin, and HMB45. Based on these
results, a poorly differentiated synovial sarcoma was
diagnosed.
As the patient developed severe anemia, hypoproteine-
mia and severe edema, she was treated with a bloodFigure 1 A clinical image showing a cauliflower-like lesion that
measured 15× 20 cm over the buttock region.transfusion, fluid infusion, supplementation with albu-
min and plasma, and regular dressing changes to main-
tain stable vital signs. However, her condition
deteriorated dramatically and she rapidly developed sys-
temic edema. As a result, she developed dyspnea, anor-
exia and anuria (<100 mL/d). The patient died of
respiratory failure within a week after admission.
Discussions
Synovial sarcoma is the third most common histological
type of soft tissue sarcoma of the extremities, which
mainly affects adolescents and young adults [4]. It is
slightly more common in men than in women, with a
male-to-female ratio of 3:2 [5]. Despite its name, synovial
sarcoma does not originate from synovial tissue, but from
multipotent stem cells that differentiate into mesenchymal
and/or epithelial structures [6]. It is characterized by a
unique t(X;18)(p11;q11) chromosomal translocation,
which leads to the formation of the SS18-SSX fusion gene
[7]. Currently, the best treatment for synovial sarcoma
remains undefined, and complete surgical excision of the
tumor mass followed by adjuvant radiotherapy and/or
chemotherapy is the preferred current choice [8].
Synovial sarcoma often has no specific clinical presen-
tations that distinguish it from other sarcomas. Typic-
ally, it presents as a slowly enlarging, deep-seated mass,
which is sometimes slightly painful. It is often misdiag-
nosed as a benign lesion, and simple excision is per-
formed without adequate pre-surgical evaluation. In
particular, as the majority of subcutaneous soft-tissue
lesions are benign or inflammatory, simple excision is
often performed without a biopsy by physicians and sur-
geons who do not have specific training in oncology [9].
As a result, some aggressive tumors, including synovial
sarcoma, can recur within years. Therefore, an early
diagnosis is extremely important for the successful treat-
ment of soft tissue synovial sarcoma. Subcutaneous sar-
comas have been reported to account for approximately
30 % of all soft tissue sarcomas [9]. In our case, the first
clinical sign of synovial sarcoma was a slightly painful
subcutaneous mass, and the mass was excised simply.
The poor outcome of our patient further stresses the im-
portance of adequate pre-surgical evaluation and post-
surgical pathological analysis in the management of a
subcutaneous mass.
Although synovial sarcomas are a high-grade soft tis-
sue malignancy, most are characterized by slow growth.
The mass may be present for an extended period before
presentation and rapid spread and early deaths are seen
only occasionally. In the present case, the disease pro-
gressed rapidly and the patient died within 4 months of
symptom recognition. Given the small tumor size at
presentation and the subsequent rapid disease progres-
sion, we surmise that local invasion and lymph node
Figure 2 Magnetic resonance images revealing a large heterogeneous, irregular mass in the buttocks (A, arrow) and involvement of
the pelvic (B, arrows) and inguinal lymph nodes (C, arrow).
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local excision of the mass. Therefore, a wide excision
plus adjuvant radiotherapy and/or chemotherapy could
have been performed. In addition, for the local excision
of a subcutaneous tumor, violation of the underlying
fascia may facilitate tumor local invasion, as the fascia
provides an excellent deep barrier to tumor spread [9].
Overall, benign tumors should be treated with a mar-
ginal excision, whereas malignant tumors should be
widely excised. It is important to obtain adequate abla-
tive margins and prevent local recurrence in patients
with synovial sarcoma [10].
The development of a non-healing wound that does
not respond to conventional antibiotic therapy and local
wound care is another interesting point of our case. Al-
though cancer has been identified to be a common cause
of non-healing wounds [11], there have been very few
reports of patients with synovial sarcoma who developedFigure 3 H&E staining of the synovial sarcoma. The tumor is
characterized by the presence of numerous small round cells with a
high nucleocytoplasmic ratio. Magnification: 100×.a non-healing wound. Several reasons may explain the
development of a non-healing wound in our patient.
Firstly, the sarcoma itself can give rise to wounds. Sec-
ondly, severe edema can slow the rate of healing, as de-
hydration adversely affects optimum wound healing by
disturbing cellular metabolism and reducing circulatory
blood volume [11,12]. Finally, malnutrition may delay
wound healing, as adequate nutrition is essential for ef-
fective wound healing [11]. Interestingly, a recent report
demonstrated that a postoperative non-healing wound
that did not respond to conventional therapy was treated
successfully with the local application of 3% citric acid
ointment for 25 days in a patient with synovial sarcoma
of the knee [13].
MRI is the preferred imaging modality for the evalu-
ation of soft tissue sarcomas because of its excellent tis-
sue contrast and ability to depict the lesion in multiple
planes. It is not only useful for evaluating the extent of
the tumor and its involvement of adjacent soft-tissue
structures, but also for differentiating tumor from
muscle tissue and depicting the involvement of neuro-
vascular structures, tendons, fascial/fat planes and bone
marrow. On MR images, lesion margins of synovial sar-
comas are well defined in 53 to 91% of cases and poorly
defined in 9 to 47% [14]. In our case, the lesion was ir-
regular and poorly confined, which was perhaps due to
the fact that MRI was performed after local excision and
local invasion had occurred. Therefore, preoperative
MRI investigations might be more useful for making an
early diagnosis of synovial sarcoma. If the findings on
preoperative MRI are doubtful, an open or needle biopsy
should be performed.
Synovial sarcoma has three major histological sub-
types: the biphasic, monophasic and poorly differentiated
types [14]. The co-existence of epithelioid cells and spin-
dle cells is a hallmark of the biphasic subtype, while the
monophasic subtype is entirely composed of spindle
Figure 4 Immunohistochemically stained sections indicating that the tumor cells are strongly positive for vimentin (A) and calretinin
(B), moderately positive for CD99 (C) and epithelial membrane antigen (D), and partially positive for cytokeratin (E) and Ki67 (F).
Magnification: 100×.
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that lacks spindle cells and comprises primitive small
round cells. Although there is a strong association be-
tween the poorly differentiated subtype and a poor prog-
nosis, this variant of synovial sarcoma shares
immunological, ultrastructural and molecular character-
istics with the usual form of synovial sarcoma and is
often diagnostically challenging [15,16]. Poorly differen-
tiated synovial sarcoma can be further divided into three
types: a large cell epithelioid variant, a small cell variant
and a high-grade spindle cell variant [15]. In the present
case, the presence of numerous small round cells with a
high nucleocytoplasmic ratio was seen. This led to the
initial diagnosis of a poorly differentiated synovial sar-
coma, which was perhaps a small cell variant.
Immunohistochemically, most synovial sarcomas are
positive for vimentin, cytokeratin and EMA, but have a
lower immunoreactivity for S-100 and CD34 [8]. Al-
though they often co-express both cytokeratin and
EMA, only one of them was positive in some cases [17].
Positive staining for CD99 and bcl-2 is also present in
many cases of synovial sarcoma [8]. In addition,expression of calretinin, varying from focal to diffuse, is
commonly seen in synovial sarcomas [18]. Our case was
strongly positive for vimentin and calretinin, moderately
positive for CD99 and EMA, and only partially positive
for cytokeratin. In addition, cytogenetics also plays an
important role in the diagnosis of synovial sarcoma, es-
pecially the poorly differentiated subtype, since the re-
ciprocal chromosomal translocation t(X;18) is highly
specific for synovial sarcoma; however, this was not per-
formed in our case.
Although curative resection and adjuvant irradiation
can improve the local control of synovial sarcoma, me-
tastases eventually develop in most patients. The lung
and skeleton are the most commonly affected sites. Re-
gional lymph nodes are involved in 10 to 23% of
patients. In our case, although lung metastasis was not
detected, pelvic and inguinal lymph node involvement
was observed. The pitting edema could be caused by
lymphedema due to the presence of lymph node metas-
tases [19]. Patients who develop metastatic soft tissue
sarcoma are incurable in most cases, and judicious use
of systemic treatment may provide symptom palliation,
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Unfortunately, our patient deteriorated rapidly and died
despite systemic therapy.
Conclusions
In conclusion, we report a case of synovial sarcoma of
the buttocks that presented with a non-healing wound
and rapid progression after local resection. Despite slow
growth in most cases, synovial sarcoma can be fatal
within months of recognition if improperly managed.
Our case stresses the importance of adequate preopera-
tive evaluation and postoperative pathological analysis in
the management of a subcutaneous mass.
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